https://www.avient.com/sites/default/files/resources/Investor%2520Day%2520-%2520May%25202012%2520-%2520Global%2520Engineered%2520Materials.pdf
Nikrant Page 67 United States 36% Europe 36% Canada 2% Asia 20% Latin America 2011 Revenue: $0.6 Billion2011 Revenue: $0.6 Billion SolutionsSolutions At a Glance Global Specialty Engineered Materials Appliance 6% Building & Construction 3% Wire & Cable 14% Electrical & Electronics 14%Consumer 21% Packaging 5% Industrial 8% Misc. 3% HealthCare 5% Transportation 21% America 6% 2011 Revenue by Industry Segment2011 Revenue by Industry Segment 1.1% 1.3% 3.4% 5.1% 9.6% 8.0% 12-16% 2006 2007 2008 2009 2010 2011 2015 Operating Income % of Sales Target Expanding ProfitsExpanding Profits Page 68 Value Proposition • GSEM is a global leader providing complete specialty solutions encompassing innovative technologies and services to enable customer success Transformation Highlights • Dramatic turnaround of the Engineered Materials business through mix improvement and specialty focus Value Proposition and Transformation Highlights Global Specialty Engineered Materials improvement and specialty focus • GLS acquisition successfully integrated, having more than doubled earnings in 3 years • PolyOne culture and strategy now engrained worldwide • Expansion into healthcare with dedicated resources > $15B Addressable Market Page 69 • Polymer design, formulation and service expertise • Broad, global technology base and regional centers of excellence • Ten innovation centers around the world Key Differentiators Global Specialty Engineered Materials • Ten innovation centers around the world • Specialty brand leadership with PolyOne, GLS, NEU and ECCOH • Ability to leverage global key account team Page 70 From Volume Commodity-driven product portfolio To Value Specialty technology and solutions EM North America Transformation Volume Sales Gross Margin $ Mix Transformation – Executing the Strategy Global Specialty Engineered Materials 2006 2011 2006 2011 2006 2011 Page 71 $12 $29 Operating Income ($ in millions) • Provided access to new customers in specialized, high-growth markets such as healthcare and consumer • Strategic partner to many of the world’s best-known companies GLS Integration Success 16.9% 8.2% 2007 2011 2007 2011 Working Capital % of Sales • Complementary global footprint provided additional cross-selling opportunities • Opportunity to expand margins and drive working capital improvement while remaining customer-focused Page 72 $1.3 $27.6 2006 2011 Healthcare Revenue • Investment in dedicated healthcare team to drive penetration and growth • Leverage product portfolio globally & win specialty business Areas of Focus Global Specialty Engineered Materials $10.5 $117.9 2006 2011 Consumer Revenue 2006 2011globally & win specialty business in targeted markets • Aggressively commercialize specialty innovation platforms • Utilize our innovation centers to influence OEM design (Revenue in $ millions) Page 73 • Carbon Nanotube Formulations � Applications: Semiconductor equipment, hard drives � Customer benefits: Scrap cost reduction and clean conductivity • Thermally Conductive Solutions Applications: Sockets and bulb holders for LED lighting Key Innovations Global Specialty Engineered Materials � Applications: Sockets and bulb holders for LED lighting � Customer benefits: Cost reduction, energy saving, and design flexibility • FDA-Regulated TPEs � Applications: Food packaging seals, intravenous delivery systems, medical stoppers, prefilled syringes � Customer benefits: Clean and safe elastomers for highly regulated applications Page 74 Critical Imperatives and 2015 Goal Global Specialty Engineered Materials Critical Imperatives • Commercialize critical new technology platforms • Manage the mix as we continue to drive the transformation • Global translation of commercial successes 2015 Goal • 12 - 16% return on sales Page 75 Page 76
https://www.avient.com/products/thermoplastic-elastomers/versaflex-hc-thermoplastic-elastomers
Learn about overmolding, material selection to enhance function, and design considerations that can help you address challenges and delight customers
https://www.avient.com/resource-center/knowledge-base/article/strategies-manage-your-carbon-footprint
Globally, as of September 2023, almost 3,400 companies have set science-based goals – with 2,400 of those being net-zero commitments – in order to address greenhouse gas emission concerns (Science Based Targets).
https://www.avient.com/sites/default/files/2023-08/Maxxam BIO Bio-Based Polyolefin Formulations Product Bulletin.pdf
KEY CHARACTERISTICS Formulated with bio-based resin and/or 10–50% filler from renewable plant sources, Maxxam BIO formulations: • Reduce product carbon footprint • Achieve equivalent performance to standard polyolefin formulations • Provide good stiffness, durability, impact resistance and UV stability • Deliver good surface finish and are easy to color • Enable customized performance characteristics depending on application need • Offer food contact compliance MARKETS AND APPLICATIONS Maxxam BIO formulations are suitable for use across many industries and applications where traditional polyolefin materials are used, including: • Transportation Interior Applications - Decorative profiles, trunk side liners, pillars, T-cup • Industrial - Structural parts, furniture • Consumer - Household goods, personal care items, packaging, office supplies, food contact applications • Electrical and Electronic – Housings, buttons, junction boxes SUSTAINABILITY BENEFITS • Formulated with bio-based resin and/or 10–50% natural filler • Utilize natural filler from renewable plant sources including olive seed based powder and cellulose fiber • Offer a lower product carbon footprint compared to traditional petroleum-based feedstock • Can be recycled at end of life PRODUCT BULLETIN CHARACTERISTICS UNITS Maxxam BIO MX5200-5036 Natural FD Maxxam BIO MX5200-5030 Natural FD Maxxam BIO MX5200-5030 Natural FD X1 Maxxam BIO MX5200-5001 RS HS Natural Maxxam BIO MX5200-5033 RS HS Natural Maxxam BIO MX5200-5034 RS HS Natural Maxxam BIO MX5200-5035 RS HS Natural Filler/Reinforcement Unfilled Unfilled Unfilled 30% Glass Fiber 10% Mineral 20% Mineral 30% Mineral Density (ISO 1183) g/cm 0.90 0.90 0.90 1.12 0.96 1.03 1.12 Tensile Modulus (ISO 527-1) @ 23°C MPa 1500 1000 1000 6400 1350 1650 2100 Tensile Stress (ISO 527-2) @ 23°C MPa 27.0 20.0 20.0 75.0 13.0 14.0 15.0 Tensile Strain at Break (ISO 527-2) @ 23°C % 5 50 50 3.0 50 37 18 Charpy Notched (ISO 179) kJ/m 5 20 25 10 12 10 10 CHARACTERISTICS UNITS Maxxam BIO MX5200-5023 RS HS HI Natural 70 Maxxam BIO MX5200-5025 RS HS Natural 70 Maxxam BIO MX5200-5004 RS HS Natural 70 Maxxam BIO MX5200-5003 RS Natural 70 Maxxam BIO MX5200-5009 RS HS Natural 70 Maxxam BIO MX5200-5024 RS HS Natural 70 Maxxam BIO MX5200-5022 RS HS Natural 70 Filler/Reinforcement 15% Olive Seed Based 25% Olive Seed Based 30% Olive Seed Based/ 10% Mineral 35% Olive Seed Based/ 5% Mineral 15% Olive Seed Based/ 17% Glass Fiber/ Mineral 20% Olive Seed Based/ 20% Glass/ Mineral 10% Olive Seed Based/ 20% Mineral Density (ISO 1183) g/ccm 1.00 1.15 1.10 1.07 1.09 1.25 1.10 Tensile Modulus (ISO 527-1) @ 23°C MPa 1750 2000 2700 2500 3800 3500 4100 Tensile Stress at Break (ISO 527-2) @ 23°C MPa 21.0 20.0 30.0 20.0 40.0 35.0 42.0 Tensile Strain at Break (ISO 527-2) @ 23°C % 24 5 3 5 3 4 2 Notched Izod (ISO 180) kJ/m 15 7 3 2 5 15 7 MAXXAM BIO POLYOLEFINS – BIO-BASED RESIN – TECHNICAL PERFORMANCE MAXXAM BIO POLYOLEFINS – OLIVE SEED BASED FILLER – TECHNICAL PERFORMANCE CHARACTERISTICS UNITS Maxxam BIO MX5200-5029 NF HI UV Black X1 Maxxam BIO MX5200-5032 NFS UV Natural Maxxam BIO MX5200-5020 NF/NFS UV Natural X1 Maxxam BIO MX5200-5016 NF Natural Filler/Reinforcement 10% Cellulose Fiber 20% Cellulose Fiber 30% Cellulose Fiber 40% Cellulose Fiber Density (ISO 1183) g/ccm 0.95 1.00 1.02 1.07 Tensile Modulus ISO 527-1) @ 23°C MPa 1550 1750 2640 3600 Tensile Stress at Break (ISO 527-2) @ 23°C MPa 33 30 48 55 Tensile Strain at Break (ISO 527-2) @ 23°C % 8 12 9 4 Charpy Notched Impact Strength (ISO 179/1eA) kJ/m2 5 6 5 5 Charpy Unnotched Impact Strength (ISO 179/1eU) kJ/m2 33 49 38 30 MAXXAM BIO POLYOLEFINS – CELLULOSE FIBER FILLER – TECHNICAL PERFORMANCE Copyright © 2023, Avient Corporation.
https://www.avient.com/knowledge-base/article/strategies-manage-your-carbon-footprint
Globally, as of September 2023, almost 3,400 companies have set science-based goals – with 2,400 of those being net-zero commitments – in order to address greenhouse gas emission concerns (Science Based Targets).
https://www.avient.com/sites/default/files/resources/Overmolding_of_Thermoplastic_Elastomers_Engineered_solutions_for_consumer_product_differentiation.pdf
Overmolding of Thermoplastic Elastomers: Engineered solutions for consumer product differentiation Krishna Venkataswamy, Rajesh Varma and Walter Ripple, Thermoplastic Elastomers Division,GLS Corporation, 833, Ridgeview Drive, McHenry, IL 60050 Introduction Overmolding Thermoplastic Elastomers (TPEs) has come of age.
TPEs provide a number of benefits to address these market trends such as a soft-touch, non-slip grip, while maintaining required performance properties such as good oil/grease resistance, toughness, abrasion resistance, and vibration damping.
Figure 9: TPE Overmold creates value in Hand Tools Ergonomics Electronics/Office Equipment: TPE overmolding in this market area is growing at a rapid rate.
https://www.avient.com/products/polymer-additives/anti-counterfeiting/plastiward-counterfeit-protection
Corporate Literature
https://www.avient.com/idea/rise-above-four-common-lightweighting-mistakes
Generally, replacing a metal component with a plastic one results in a 50 percent weight reduction, so the math is attractive to designers striving to reach Corporate Average Fuel Economy (CAFE) targets.
https://www.avient.com/products/polymer-additives/reheat-additives-pet/colormatrix-smartheat-rhc
Corporate Literature
https://www.avient.com/knowledge-base/case-study/pain-therapy-device-stands-out-peers
Biowave Corporation of Norwalk, Conn., is a medical device manufacturer whose pain therapy products help patients manage pain and reduce the use of medications such as opiates.